Literature DB >> 5865379

Fatty acids in esters and cerebrosides of human brain in phenylketonuria.

J L Foote, R J Allen, B W Agranoff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5865379

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


× No keyword cloud information.
  9 in total

1.  The fatty acid composition of cerebrosides and sulfatides in a case of adult metachromatic leukodystrophy.

Authors:  H Pilz; R Heipertz
Journal:  Z Neurol       Date:  1974-03-29

Review 2.  Phenylketonuria: a review.

Authors:  J S Yu
Journal:  Postgrad Med J       Date:  1970-07       Impact factor: 2.401

3.  Morphological aspects of mental retardation.

Authors:  L Crome
Journal:  Proc R Soc Med       Date:  1972-07

4.  Lipid changes in the brain in phenylketonuria.

Authors:  J N Cumings; I K Grundt; T Yanagihara
Journal:  J Neurol Neurosurg Psychiatry       Date:  1968-08       Impact factor: 10.154

5.  Infantile spongy degeneration of the central nervous system associated with glycogen storage and markedly fatty liver.

Authors:  Y Takei; G B Solitare
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-02       Impact factor: 10.154

6.  The fatty acid composition of major glycosphingolipids (cerebrosides and sulfatides) in human cerebral white matter measured by a simple micromethod.

Authors:  R Heipertz; H Pilz; W Scholz
Journal:  J Neurol       Date:  1976-07-15       Impact factor: 4.849

7.  Effects of alpha-methylphenylalanine plus phenylalanine treatment during development on myelin in rat brain.

Authors:  R C Johnson; S N Shah
Journal:  Neurochem Res       Date:  1980-07       Impact factor: 3.996

8.  "PKU bodies": characteristic inclusions in the brain in phenylketonuria.

Authors:  F T Oteruelo
Journal:  Acta Neuropathol       Date:  1976-12-21       Impact factor: 17.088

9.  Inhibition of brain and liver 3-hydroxy-3-methylglutaryl-CoA reductase and mevalonate-5-pyrophosphate decarboxylase in experimental hyperphenylalaninemia.

Authors:  M Castillo; M F Zafra; E Garcia-Peregrin
Journal:  Neurochem Res       Date:  1988-06       Impact factor: 3.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.